252
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Patients above Sixty Years Lymphoma Treated with a New Strategy of Age with Hodgkin's

, , &
Pages 659-667 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ajay Major, Matthew W. Jackson, Derek E. Smith, Manali Kamdar & Rachel Rabinovitch. (2019) Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Leukemia & Lymphoma 60:5, pages 1234-1243.
Read now
A. Kolstad, O. Nome, J. Delabie, G. F. Lauritzsen, A. Fossa & H. Holte. (2007) Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma. Leukemia & Lymphoma 48:3, pages 570-576.
Read now

Articles from other publishers (21)

Cathy Burton, Pamela Allen & Alex F. Herrera. (2024) Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease. American Society of Clinical Oncology Educational Book 44:3.
Crossref
Andrew M. Evens, Marshall McKenna, Yun Kyoung Ryu Tiger & Jenica N. Upshaw. (2023) Hodgkin lymphoma treatment for older persons in the modern era. Hematology 2023:1, pages 483-499.
Crossref
Manish Sharma, Pankaj Goyal, Rajesh Ranjan, Udip Maheshwari, Dinesh Bhurani, Chaturbhuj Aggarwal, Venkata Pradeep Babu Koyyala, Parveen Jain, Narendra Agrawal & Rayaz Ahmed. (2022) Clinical and Epidemiological Profile of Elderly Hodgkin’s Lymphoma in India. Cureus.
Crossref
Boris Böll & Andrew M. Evens. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma 297 315 .
Andrew M. Evens, Jordan Carter, Kah Poh Loh & Kevin A. David. (2019) Management of older Hodgkin lymphoma patients. Hematology 2019:1, pages 233-242.
Crossref
Andrew M. EvensRanjana H. AdvaniIrene B. HelenowskiMichelle FanaleSonali M. SmithBorko D. JovanovicGregory R. BociekAndreas K. KleinJane N. WinterLeo I. GordonPaul A. Hamlin. (2018) Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma. Journal of Clinical Oncology 36:30, pages 3015-3022.
Crossref
Magnus Björkholm, Caroline E. Weibull, Sandra Eloranta, Karin E. Smedby, Ingrid Glimelius & Paul W. Dickman. (2018) Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma—A population‐based study from Sweden. European Journal of Haematology 101:1, pages 106-114.
Crossref
K.D. Kaplanov', T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva & N.B. Lavrishina. (2017) The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity. Clinical oncohematology 10:3, pages 358-365.
Crossref
Sameer A. Parikh, Thomas M. Habermann, Kari G. Chaffee, Timothy G. Call, Wei Ding, Jose F. Leis, William R. Macon, Susan M. Schwager, Kay M. Ristow, Luis F. Porrata, Neil E. Kay, Susan L. Slager & Tait D. Shanafelt. (2015) H odgkin transformation of chronic lymphocytic leukemia: I ncidence, outcomes, and comparison to de novo H odgkin lymphoma . American Journal of Hematology 90:4, pages 334-338.
Crossref
Boris Böll & Andrew M. Evens. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 271 286 .
Deepa Jagadeesh, Catherine Diefenbach & Andrew M. Evens. (2013) XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes. Hematological Oncology 31:S1, pages 69-75.
Crossref
Stephen J. ProctorJennifer WilkinsonGail JonesGillian C. WatsonHelen H. LucraftTryfonia Mainou-FowlerDominic CulliganMichael J. GallowayKatrina M. WoodRichard J. Q. McNally, Peter W. James & John R. Goodlad. (2012) Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study. Blood 119:25, pages 6005-6015.
Crossref
Jan SjöbergCat Halthur, Sigurdur Y. KristinssonOla Landgren, Ulla Axdorph NygellPaul W. Dickman & Magnus Björkholm. (2012) Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009. Blood 119:4, pages 990-996.
Crossref
Andrew M. EvensIrene HelenowskiErika RamsdaleChadi NabhanReem KarmaliBritt HansonBenjamin ParsonsScott SmithAnnette LarsenJune M. McKoy, Borko JovanovicStephanie GregoryLeo I. Gordon & Sonali M. Smith. (2012) A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era. Blood 119:3, pages 692-695.
Crossref
Boris BöllHenning BredenfeldHelen GörgenTeresa HalbsguthHans T. EichMartin SoeklerJana MarkovaUlrich KellerUllrich GraevenStephan KremersMichael Geissler, Guido Trenn, Michael FuchsBastian von TresckowDennis A. EichenauerPeter BorchmannAndreas Engert. (2011) Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood 118:24, pages 6292-6298.
Crossref
Teresa V. Halbsguth, Boris Böll, Peter Borchmann & Volker Diehl. (2011) The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma. Current Hematologic Malignancy Reports 6:3, pages 164-171.
Crossref
Peter Borchmann, Teresa Halbsguth & Stephen J. Proctor. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma 259 272 .
Andrew M. Evens & Sandra J. Horning. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 367 403 .
Teresa V. HalbsguthLucia NogováHorst MuellerMichal Sieniawski, Dennis A. EichenauerThomas SchoberHiltrud Nisters-BackesPeter BorchmannVolker DiehlAndreas EngertAndreas Josting. (2010) Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 116:12, pages 2026-2032.
Crossref
T. Halbsguth & P. Borchmann. (2010) Therapiestrategien für die Behandlung des Hodgkin-Lymphoms bei älteren PatientenTherapy strategies for the treatment of Hodgkin’s lymphoma in elderly patients. Der Onkologe 16:1, pages 55-62.
Crossref
Stephen J. Proctor, Jo White & Gail L. Jones. (2005) An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. European Journal of Haematology 75:s66, pages 63-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.